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Abstract: Inflammation affects the reliability of ferritin. The serum level of transferrin receptor protein (sTfR) represents 
true demand of iron in the body. This study attempts to identify levels of sTfR and correlate the trends of sTfR/ferritin 
index with BMI in the population of Karachi. 132 gender matched volunteers between the ages of 20-60 years were 
recruited for this cross-sectional study. BMI was calculated using the formula: (weight in kg / height in m2). Following 
groups were made according to South Asian criteria of BMI; Group A: normal weight (18.0-22.9 kg/m2), Group B: 
overweight (23.0-24.9 kg/m2), Group C: obese (>25.0 kg/m2). Serum ferritin, sTfR and CRP levels were determined 
using ELISA kits. Statistical comparisons were performed using Mann Whitney U and Spearman’s rank correlation, 
where p<0.05 was considered significant. The results identified increased in TIBC, sTfR, ferritin and CRP in obese as 
compared to normal weight individuals (p<0.001). sTfR/ferritin ratio was 0.822 which signifies increased risk of acute 
myocardial infarction in group C. Serum iron (r=-0.359,p=0.004) showed negative correlation with BMI while serum 
ferritin (r=0.237,p< 0.001) and sTfR (r=0.263,p= 0.036) levels were positively associated to BMI. This study highlights 
a novel finding that sTfR is most likely a better clinical measure of iron status in inflammatory conditions as its 
expression is effected by erythropoiesis and not by inflammation. Risk of Acute myocardial infarction can also be 
predicted by increased sTfR/ferritin ratio. 
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INTRODUCTION  
 
Presence of iron in hemoglobin makes its role extremely 
essential to health. Low iron levels results in iron 
deficiency anemia (IDA) and a decreased functional 
capacity. In cardio-myopathic patients, IDA has been 
commonly found to increase morbidity and mortality 
(Szachniewicz et al., 2003). Iron deficiency can be 
detected by detecting low levels of ferritin or increased 
sTfR levels. Conventionally clinicians rely on ferritin 
levels for the assessment of iron stores present in the 
body.  
 
Ferritin is a protein responsible for iron storage and a 
decreased level is associated with iron deficiency. 
However ferritin is an acute phase reactant that increases 
in inflammatory conditions thus becoming elevated 
despite normal or low iron content (Baynes et al., 1986). 
Therefore, in inflammatory chronic conditions, ferritin is 
an unreliable marker (Fitzsimons and Brock, 2001). 
Similarly a new approach is required in diagnosing iron 
deficiency in the obese population. It has been shown that 
adipose tissue is responsible for secreting substances 
called adipokines that cause subclinical inflammation in 
obese individuals (Greenberg and Obin, 2006). In 
addition it is the obese population that is more 
predisposed to developing iron deficiency (Yanoff et al., 
2007). In such cases of inflammation, sTfR (soluble 
Transferrin Receptors) level has been hypothesized to be 
a more reliable marker for iron status (Baillie et al., 
2003). sTfR are cleavage products of the trans-membrane 
transferrin receptors expressed on the cell membrane of 
iron requiring cells. The levels of sTfR in the serum 
correlate with the level of receptors expressed on the cell 
surfaces of iron requiring tissue, and therefore serve as a 
marker for tissue iron requirement. 
 
The debate still persists whether sTfR is a more reliable 
marker as compared to ferritin in diagnosing iron 
deficiency (Braga et al., 2014). Researches have tried to 
observe trends of different iron parameters in their local 
populations and analyzed the results to produce better cut 
off ranges in order to increase specificity and sensitivity 
of the above tests. Discrepancies in normal values of iron 
parameters in different ethnic and geographical 
populations have been recorded (Braga et al., 2014). In 
this study we attempt to identify and correlate the trends 
of different parameters of iron profile with the BMI 
variations in the population of Karachi.  
 
MATERIAL AND METHODS 
 
Total of 132 apparently healthy gender matched 
individuals between the ages of 20-60 year were recruited 
for this cross-sectional study after being questioned about 
their medical, surgical and personal history to match their 
compatibility with the inclusion of this study. Exclusion 
criteria included all conditions which led to change in the 
body iron stores or cause inflammation, such as 
pregnancy, smoking, alcoholism, hemoglobinopathies, 
diabetes mellitus, bleeding disorders, any acute illness 
during last 1 month, as well as iron deficiency as seen on 
complete blood picture (CP).  *Corresponding author: e-mail: sadia.fatima@aku.edu 
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The research protocol was permitted by the research 
ethics committee, Basic Medical Sciences Institute, 
Jinnah Postgraduate Medical Centre, (No. F.1-
2/2013/BMSI-E.COMT/007/JPMC). All the participants 
were asked to complete a verbal and written informed 
consent. 
 
BMI was calculated using the formula: (weight in kg / 
height in m2) (Garrow and Webster, 1984) after 
measuring weight and height of all the subjects in 
kilograms and meters respectively, using Stadiometer (ZT 
-120 Health Scale, made in China). The Hip and waist 
circumference was measured by standard techniques 
(World Health, 2011).The subjects were divided into; 
Group A: normal weight (18.0-22.9 kg/m2), Group B: 
overweight (23.0-24.9 kg/m2), Group C: obese (>25.0 
kg/m2) according to South Asian criteria of BMI 
(Sharma, 2013, Singh et al., 2008). 
 
Serum ferritin, sTfR and CRP levels in serum samples 
were determined using a commercially available 
sandwich ELISA kit (cat # YHB2785Hu; BioCheck 
(Foster city, CA, USA, cat #. BC- 1025) and Dia Source, 
(Immunoassay SA. Belgium, ref # KAPDB4360, 
respectively.  
 
Statistical analysis of the data was achieved using the 
SPSS for Windows 19 software package (SPSS Inc., 
Chicago, IL). A descriptive statistical analysis of 
continuous variables was performed. Data on continuous 
variables i.e. biophysical and biochemical parameters 
were presented as Mean + Standard Deviation (SD). 
Statistical comparisons were performed by using Mann 
Whitney U test for non-parametric variables. Associations 
between circulating sTfR levels and BMI were 
determined using Spearman’s rank correlation. 
Associations were considered significant if P < 0.05. 
RESULTS 
 
A total of 132 subjects were divided into Group A, B, C 
according to their BMI with reference to the South Asian 
Criteria (Sharma, 2013, Singh et al., 2008).  
 
Biophysical parameters 
Mean age of the study subjects was 24.7 ± 6.34 years and 
mean BMI was 17.9 ± 2.21 kg/m2. A trend of raised BMI 
was seen from group A–C (p=<0.001), whereas no 
significant change was noted in WHR in the study groups 
(p=>0.5) (table 1). 
 
Biochemical parameters 
There was a significant decrement in the hemoglobin 
levels (p= 0.02); serum iron levels (p < 0.001) and 
Transferrin saturation (p<0.001) from group A-C. TIBC 
and serum transferrin receptor protein on the other hand 
demonstrate a rise in group C when compared to Group A 
(p<0.001). This depicts a true picture of iron deficiency in 
Group C. Unexpectedly, serum ferritin levels were 
elevated in both group B and C as compared to the group 
A (p<0.001), respectively. In group C, sTfR/ferritin ratio 
was also calculated to be 0.822 which is suggestive of 
increased risk of acute myocardial infarction in obese 
individuals. CRP also showed a great surge in group C 
individuals as compared to group A individuals (p<0.001) 
(table 1). Spearman rank correlation portrayed a negative 
correlation of serum iron (r=-0.359, p=0.004) with BMI 
while serum ferritin (r=0.237, p< 0.001) and sTfR 
(r=0.263, p= 0.036) levels were positively associated to 
BMI (fig I A-C). 
 
DISCUSSION 
 
The study was focused on assessment of serum transferrin 
receptor (sTfR) levels in specific BMI groups with 
Table 1: Biophysical & Biochemical Parameters of the Study Subjects 
 
Variable Group A Normal Mean ± SD (n=44) 
Group B Overweight 
Mean ± SD (n=44) 
Group C Obese 
Mean ± SD (n=44) p value 
Age (year) 36.59 ± 7.27 35.1±3.62 34.43 ± 8.16 >0.05 
BMI (kg/m2 ) 21.41 ± 1.93 24.3±0.55 29.99 ± 4.16 <0.001 
Waist to Hip ratio 0.89 ± 0.11 0.85±0.11 0.88 ± 0.08 >0.05 
Haemoglobin (g/dl) 13.11 ± 1.84 12.8±1.56 10 ± 1.53* 0.02 
Ferritin (ng/dl) 11.25 ± 7.60 19.3±12.8* 22.8 ± 22.46* <0.001 
Iron (mg/dl) 2.18 ± 1.42 2.25±3.00 1.08 ± 1.28* <0.001 
TIBC ( µg/dl) 1.94 ± 1.08 1.62±0.30* 3.31 ± 0.78* <0.001 
Transferrin Saturation (%) 50 ± 8.90 45.6±7.20 20.23 ± 2.10* <0.001 
sTfR (mg/l) 6.88 ± 0.68 8.07±4.58 18.76 ± 0.75# >0.001 
CRP (mg/dl) 3.48 ± 5.33 4.25±0.59 8.96 ± 5.33* <0.001 
sTfR/Ferritin ratio 0.61 0.42 0.822# <0.001 
Where: BMI (Body mass index), TIBC (total iron binding capacity), sTfR (serum transferrin receptor protein) & CRP (C-reactive 
protein). P value <0.05 considered statistically significant 
*statistically significant when compared to group A 
#statistically significant when compared to group A & B 
Faiza Alam et al 
Pak. J. Pharm. Sci., Vol.30, No.2, March 2017, pp.537-540 539
reference to South Asian criteria and finding out whether 
the serum transferrin receptor level is a better marker of 
iron status compared to ferritin levels. 
 
In this study the sTfR levels are elevated in obese group 
individuals although, the individuals did not have any 
apparent iron deficiency (table 1), which was initially 
confirmed by the microscopic picture. So far the sTfR cut 
off levels are not well documented in South Asian 
population, this study is highlighting the levels of sTfR in 
Pakistani population. The increased sTfR levels in this 
study indicate the functional picture of iron in the body. 
This suggests that the demand of iron is more in obese 
individuals probably because the iron is sequestered 
within the macrophages and as a result sTfR increases to 
fulfill the demand. 
 
The results of this study show that the serum ferritin 
levels of obese were higher than those of overweight 
individuals. It was also seen that with an increase in BMI 
there is a corresponding increase in the C reactive protein 
(CRP) in the body (Table 1). CRP is an acute phase 
reactant that is produced by the liver under the influence 
of adipokine released by the adipocytes in the body (Alam 
et al., 2014, Brooks et al., 2010, Choi et al., 2013). Since 
an excess of adipocytes means additional adipokine in 
circulation hence the body enters a state of sub-clinical 
inflammation. This leads to a decrease in iron levels of 
the body due to the inflammatory mediated sequestration 
of iron within the reticulo-endothelial system (Karl et al., 
2009). Although the increase in ferritin level trend may 
seem vague but as identified by anoother study of our 
group; its levels increase when the body is in a state of 
subclinical inflammation such as obesity (Alam et al., 
2014) . Given that it could be postulated that ferritin is 
responsible for giving false positive results for IDA in 
overweight and obese (fig. 1B) and thus, sTfR is likely to 
be the best clinical measure of iron status in these subjects 
as its expression is not effected by inflammation but 
demand of erythropoiesis by the body (Zimmermann, 
2008) (fig. 1A and C).  
 
Obesity is one of the causes of increased risk for acute 
myocardial infarction (AMI). Furthermore, some studies 
have established increased serum ferritin as a risk factor 
for AMI (Holay et al., 2012). Recently attention has been 
given to evaluate whether sTfR/ferritin ratio can be used 
as a better marker in certain conditions including AMI. A 
ratio of sTfR and Ferritin provides highest sensitivity and 
specificity in this regards (Punnonen et al., 1997). The 
 
Fig. 1: Correlation of BMI with Iron Parameters 
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current study shows that sTfR/ferritin levels in obese 
group is almost near 1 (0.822), that is it is increasing from 
normal weight to obese individuals. sTfR and ferritin ratio 
has been studied in different patients of coronary artery 
diseases (CAD) elucidating an increase in sTfR and 
ferritin ratio as the disease progresses from stable angina 
to the potentially life taking AMI (Braun et al., 2004). 
Hence it is logical to conclude that an increase in sTfR to 
ferritin ratio can be a good predictor of AMI in our obese 
subjects.  
 
The limitation of this study has been its cross-sectional 
design; prospective studies would be a better evaluator. 
Relatively larger population studies are not available to 
define the cut off values of the iron parameters Pakistani 
population. However, this study proposes a causal 
connection between change in BMI, inflammation and 
low iron levels.  
 
CONCLUSION 
 
This study highlights a novel finding of increasing levels 
of sTfR in obese Pakistani population. On the contrary 
ferritin levels could not depict the true iron deficient 
status. It could be postulated that sTfR is likely to be the 
best clinical measure of iron status in obese subjects. sTfR 
is most likely a better clinical measure of iron status in 
inflammatory conditions as its expression is effected by 
erythropoiesis and not by inflammation. Furthermore; risk 
of acute myocardial infarction can also be predicted by 
increased sTfR/ferritin ratio. 
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